13F HOLDINGS REPORT
Athyrium Capital Management, LP
Quarter ended Q3 2024 · Filed November 12, 2024 · Accession 0001123292-24-000336
Total Value
$8.7M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Biora Therapeutics Inc. | 74319F305 | 10,929,762 | $5.5M | 63.12% |
| 2 | PUMA BIOTECHNOLOGY INC | PBYI | 1,256,411 | $3.2M | 36.88% |